Kluver Symposium Series: Intraventricular Hemorrhage, The Worst Type of Hemorrhagic Stroke

Chicago, IL US
May 25, 2016

This activity will disseminate knowledge about expected outcomes of IVH, the most severe form of stroke, with current standards of care and educate when and how best to use EVD thrombolysis as a tool to improve outcomes of IVH. It will discuss case examples highlighting knowledge gained, practical questions, and remaining controversies. Additionally, the course will review the recently reported results of the CLEAR III trial. This information will help attendees provide improved care for patients who suffer from intraventricular hemorrhages.

Target Audience

This activity has been designed for physicians and allied health professionals in the neurosurgery, neurology, and critical care specialties, those on stroke care teams, and others interested in the treatment of hemorrhagic stroke.

Learning Objectives

At the conclusion of this activity, the learner will be able to:

  • Define classification and grading of hemorrhagic strokes with intraventricular hemorrhage (IVH);
  • State the current evidence based practice guidelines for management of IVH;
  • Describe results of CLEAR III Trial and the impact of EVD thrombolysis on mortality and functional recovery;
  • Recall results of the CLEAR III Trial, and what subgroups of patients are most likely to benefit, and protocol steps aimed at enhancing benefit and mitigating risks of EVD thrombolysis;
  • Discuss practical clinical decisions related to specific examples of challenges regarding case selection and EVD thrombolysis goals and expected outcomes.

 

Additional information
ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
For more information, please contact:
CME Coordinator Contact Name: 
Cecilia Ehlenbach
CME Coordinator Contact Email: 
CME Coordinator Contact Phone: 
773-702-8544
Summary
Available credit: 
  • 2.50 AMA PRA Category 1 Credit™
  • 2.50 Participation
Event starts: 
05/25/2016 - 5:00pm
Event ends: 
05/25/2016 - 8:30pm
Activity opens: 
05/25/2016
Activity expires: 
11/25/2016
Quadrangle Club
1155 E 57th St
Chicago, IL 60637
United States
PLANNING COMMITTEE

Issam A. Awad, MD
John Harper Seeley Professor of Surgery
Director, Neurovascular Surgery
University of Chicago Medicine

David M. Frim, MD, PhD
Ralph Cannon Professor of Surgery
Professor of Neurology and Pediatrics
Chief, Section of Neurosurgery
University of Chicago Medicine

SPEAKERS

Distinguished Kluver Professor
Daniel Hanley, MD
The Legum Professor of Acute Care Neurology
The Johns Hopkins Medical Institutions

University of Chicago Invited Faculty
Agnieszka Ardelt, MD, PhD
Associate Professor of Neurology and Neurosurgery
Director of Neurocritical Care
University of Chicago Medicine

Regional Invited Faculty
Sepideh Amin-Hanjani, MD
Professor of Neurological Surgery
University of Illinois at Chicago
   
Sayona John, MD
Neurocritical Care
Rush University Medical Center

George A. Lopez, MD
Neurocritical Care
Rush University Medical Center
 

The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.

To register, please email us by clicking the button below. For additional information, please download the brochure below.

REGISTER HERE

Please login or create an account to proceed.